Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2384-1
Full Text
Open PDFAbstract
Available in full text
Date
January 17, 2014
Authors
Publisher
Springer Science and Business Media LLC